FACT 1 – The short-term risks of adverse effects of the COVID vaccine shots versus the risks of getting COVID-19 infection greatly favored getting the COVID shots. Now, there are rare but significant documented adverse effects of the COVID shots for the major US vaccine providers, which are Pfizer, Moderna, and Johnson & Johnson (J&J).
FACT 2 – The issuance of Emergency Use Authorizations (EUAs) is controlled by the federal Food and Drug Administration (FDA). If there were an already approved drug, the FDA could not authorize an EUA for preventing or treating that disease. The FDA, CDC, and NIH refused to analyze the safety and efficacy of ivermectin when applied to the prevention and treatment of COVID-19.
There must be proof that the drug receiving an EUA is safe and efficacious (it works) for the prevention of the disease. The FDA has issued the EUAs for the COVID vaccines from Pfizer, Moderna, and J&J. There has not been enough time to establish the long-term safety, efficacy, and length of protection of any of the vaccines given EUAs. There have now been many incidences of people that have been fully vaccinated becoming infected with COVID-19, with some deaths attributed to COVID-19 and some to the rare side effects of the vaccines.
FACT 3 – Vaccines do not kill the viruses that they are designed to prevent. Vaccines depend upon the immune response of the receiving person to generate antibodies that will resist the infection by the disease for which they were designed. Vaccines will not work as well for people that are immune compromised, which often includes the aged; those taking immune suppressing drugs; or those that having other health factors impacting their immune response including diabetes, obesity and chemotherapy.
FACT 4 – The FDA, the Center for Disease Control and Prevention (CDC), and the National Institute of Health (NIH) have made decisions to focus on the prevention of the spread of COVID-19 using EUA vaccines. There are no certified COVID vaccines currently in the US. Guidance from these organizations are focused on not spreading the virus. The failure of the FDA to certify ivermectin was a major breech of common practices since those with COVID-19 symptoms were told to quarantine for two weeks with no therapeutic drug being made available. During this time, the viral load was drastically increased and those who came in contact with the person were exposed to an increasing risk of getting the disease.
FACT-5 The government agencies have not certified any drugs to treat COVID-19 according to the CDC website. This was as of December 4, 2020.
“There are no drugs or other therapeutics presently approved by the FDA to … Current clinical management of COVID-19 consists of infection prevention “
The following news release was issued June 24, 2021.
” Under today’s EUA, the FDA is authorizing the emergency use of Actemra for the treatment of certain hospitalized patients with COVID-19. Actemra is not approved as a treatment for COVID-19.”
You can read about the process used to issue the EUA for use of Actemra, and the results noted in reducing time in the hospital and numbers of deaths.
FACT-6 – The value of ivermectin for the treatment of COVID-19 was not known at the time the WHO declared a global pandemic. Ivermectin has been used as an anti-parasitic since 1988, when it was used globally to help prevent river blindness and other parasitic diseases. It has been given to humans a total of 4 billion doses, which proves that it is a safe drug. The safety and efficacy of ivermectin in treating and preventing COVID-19 is well established, but it has not been formally evaluated by the FDA or CDC, but the NIH changed its official opinion from “do not use” to “no opinion for or against using ivermectin” for the treatment of COVID-19.
“In October 2020, the FLCCC Alliance identified, based on a review of the recent and rapidly emerging clinical trials evidence, that ivermectin, an anti-parasitic medicine, has highly potent real-world, anti-viral, and anti-inflammatory properties against SARS-CoV-2 and COVID-19. This conclusion is based not only from multiple in-vitro and animal models, but from numerous clinical trials from centers and countries around the world showing repeated, consistent, large magnitude improvements in clinical outcomes when ivermectin is used not only as a prophylactic agent but also in mild, moderate, and even severe disease states.” https://www.flccc.net
A major conclusion of the FLCCC team has been that the key to using ivermectin is to begin treatment as soon as symptoms of COVID-19 infection has been observed. The instructions of the CDC for patients showing symptoms of COVID-19 quarantine for two weeks allowed the virus to multiply unobstructed, and did not follow standard protocols for treatment of high-risk diseases.
While the CDC has not issued any therapeutic treatment protocols for COVID-19, the Front-Line Critical Care alliance has issued four protocols covering prevention of infection and in-home treatment through two stages of infection, and for the treatment of long-terms effects caused by the COVID-19 or the hospital treatment interventions.
https://flccc.net/math+ for hospital treatment
https://flccc.net/imask+ for prevention and early at-home treatment
https://flccc.net/imass for prevention and early at-home treatment in mass distribution
https://flccc.net/irecover for those suffering long-hall COVID symptoms
Meta-studies that combine results of many different studies have proven the safety and efficacy of ivermectin. These studies were done by many independent research organizations with the conclusions that ivermectin is safe and efficacious in the treatment of COVID-19. A meta-study done in the UK has documented a reduction in deaths from COVID-19 at 62% and reduction in transmission by 84% with the early use of ivermectin.
FACT-7 There has been significant disagreement between the US government health organizations and WHO about the efficacy of the one therapeutic drug recommended by the US agencies to treat COVID-19. Remdesivir has been recommended by the FDA as a treatment for COVID-19 based upon a study published in the New England Journal of Medicine (NEJM). The World Health Organization’s extensive study of remdesivir concluded that remdesivir did not reduce mortality or hospital time significantly when the study results were released on November 20, 2020. Remdesivir has a cost of ~$3,000 per dose. Ivermectin costs a few dollars for one treatment following the FLCCC protocols, if purchased in the U.S. If purchased from India, 12 mg of ivermectin costs $0.67 including all ivermectin, processing fees and currency transactions.
“WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients.”
FACT-8 There is now growing evidence that the COVID-19 vaccines are displaying longer-term adverse effects on various health conditions up to and including death. Pfizer, Moderna, and J&J now have box label warnings against possible severe complications of their vaccines. Astra-Zeneca has also had box warning requirements placed by the UK and the EU for possible side effects of its vaccine.
The box label warning requirements indicate that the COVID-19 vaccines may exhibit long-term health effects not directly related to the virus. These warnings are for heart and vascular inflammation, blood clots, Guillain-Barré syndrome attacks on nerves, with other conditions being verified as resulting from the vaccines. It is important to note that there is no true long-term data available yet for health effects of any of the vaccines. In the past, vaccines took several years to establish the long-term safety and efficacy data of vaccines. COVID-19 vaccines were given EUAs under altered rules that will be discussed below.
A video provides a discussion of what is happening to the vaccine after it is injected into a recipient of the vaccines.
Fact-9 According to surveys of those that have not been vaccinated, there is a significant majority of people that say they will not be vaccinated for COVID-19 under any circumstance. The WH and the government agencies continue to promote that unvaccinated people must get vaccinated to reduce the spread of COVID-19.
The use of ivermectin will have a higher probability of being accepted by those refusing vaccination than attempts at changing the decisions of those adverse to receiving inoculations of any of the vaccines. The results of using ivermectin at any stage of treatment for COVID-19 meet or exceed the standard treatments, with significantly better results for those that must resort to standard ICU protocols. The sooner a person receives therapeutic treatment to destroy the virus the less the consequences of the infection.
FACT-10 There needs to be a global ban enforced against the development, stockpiling, or deployment of biological weapons. There are Biosafety Level -4 labs similar to Wuhan Institute in many countries. There are at least 22 counties with known BSL-4 labs, and some very likely countries not on the list include Israel, Iran, and North Korea.
There is no international treaty that has been ratified against biological weapons that corresponds to that for nuclear non-proliferation. The International Criminal Court (ICC) and International Court of Justice (ICJ) have jurisdictions to prosecute cases involving the use of biological weapons. The development of biological weapons using gain in function techniques on viruses to make them receptive by humans should be tried by the ICC or ICF with charges of crimes against humanity, and those convicted should face penalties of death or life without parole depending upon the number of people killed or injured by the biological weapons. In additional, global financial sanctions should be engaged to punish the sponsoring country.